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Stelingen behorende bij het proefschrift:
“A systems genomics approach to identify risk loci 
and pathways to Candida infection”
1. Genetic polymorphisms that regulate complement and blood coagulation 
determine susceptibility to candidaemia (chapter 2).
2. Rather than responding uniformly to al infections via regulation of the 
same cytokines, immune responses are organized to have specific 
responses to specific fungal pathogens, and adjuvant immunotherapy 
needs to take these pathogen-specific effects into consideration (chapter 3).
3. Increased risk to candidaemia is explained by the effect of disturbed lipid 
homeostasis on the regulation of pro-inflammatory cytokines in response to 
Candida infection (chapter 3).
4. The existence of distinct genetic contributions to inflammatory responses 
to Candida infection, susceptibility, and survival indicates that modulation 
of cytokine responses alone is not sufficient to treat al candidaemia 
patients (chapter 4).
5. The genetic architecture of infectious diseases, including candidaemia, is 
different from that of immune-mediated diseases, with low frequency 
variants showing an intermediate effect in infections. 
6. Combining systems approaches with longitudinal, patient-specific clinical 
data and organ-on-chip technology wil enable us to identify novel genes 
and molecular pathways and revolutionize the drug target discovery 
process.
7. Detecting true genetic associations in sepsis requires both increased 
sample sizes and accurate phenotype delineation.
8. [Locating the gene related to a disease from scratch is like] trying to find 
a burned-out light bulb in a house located somewhere between the East and 
West coasts without knowing the state, much less the town or street the 
house is on (Francis S. Colins).
